| | Model 1 | Model 2 | Model 3 | Model 4 |
|---|
HR | 95%CI | HR | 95%CI | HR | 95%CI | HR | 95%CI |
|---|
All-cause mortality |
Pre-existing CVD group | Reference | | | | | | | |
DM group | 1.49 | 1.20 to 1.86 | 1.41 | 1.10 to 1.80 | 1.37 | 1.07 to 1.75 | 1.46 | 1.17 to 1.81 |
CVD mortality |
Pre-existing CVD group | Reference | | | | | | | |
DM group | 1.13 | 0.74 to 1.73 | 1.04 | 0.67 to 1.62 | 1.06 | 0.68 to 1.65 | 1.07 | 0.69 to 1.67 |
- aP interaction = 0.280 (all-cause mortality); P interaction = 0.113 (CVD mortality). Model 1, unadjusted; model 2, model 1 plus age, sex, body mass index, systolic BP, diastolic BP, current smoking, current alcohol consumption, 24-h urine volume, hypertension, and hyperlipidemia; model 3, model 2 plus medications; model 4, model 3 plus hemoglobin, serum albumin, serum uric acid, eGFR, cholesterol, triglyceride, high-density lipoprotein, low-density lipoprotein, and hs-CRP. DM diabetes mellitus, CVD cardiovascular disease, BP blood pressure, eGFR estimated glomerular filtration rate, hs-CRP high-sensitivity C-reactive protein, HR hazard ratio, CI confidence interval
